Search Results - "Berd, D."

Autologous ovarian tumor cells vaccine, modified with the hapten, dinitrophenyl (DNP), in platinum resistant ovarian cancer by Berd, D, Williams, S, Del Priore, G, Standiford, S, Brown, K, Pollock, T, Jaggernauth, S

Get full text

Cancer vaccines: reborn or just recycled? by Berd, D

“…The field of human cancer vaccines is currently undergoing a revival. This volume describes a variety of approaches to active immunotherapy, some traditional…”
Get more information

QS333. Lymph Node Ratio Is an Important and Independent Prognostic Factor for Patients With Stage III Malignant Melanoma by Fierro, M, Kairys, J.C, Mastrangelo, M.J, Berd, D, Sato, T, Pequignot, E, Hyslop, T, Berger, A.C

Get full text

Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases by Berd, D, Maguire, Jr, H C, Schuchter, L M, Hamilton, R, Hauck, W W, Sato, T, Mastrangelo, M J

“…To determine whether treatment with an autologous whole-cell vaccine modified with the hapten dinitrophenyl (DNP vaccine) is an effective postsurgical adjuvant…”
Get more information

Interleukin 10 production by human melanoma by SATO, T, MCCUE, P, MASUOKA, K, SALWEN, S, LATTIME, E. C, MASTRANGELO, M. J, BERD, D

“…Interleukin 10 (IL-10) has the physiological role of down-regulating cell-mediated immunity. We have recently reported that mRNA for IL-10 was present in most…”
Get full text

Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients by Berd, D, Maguire, Jr, H C, McCue, P, Mastrangelo, M J

“…We treated 64 patients with metastatic melanoma using a melanoma vaccine preceded by low-dose cyclophosphamide (CY), and monitored immunologic effects and…”
Get more information

Autologous, hapten-modified vaccine as a treatment for human cancers by Berd, D, Kairys, J, Dunton, C, Mastrangelo, M J, Sato, T, Maguire, Jr, H C

“…We have devised a novel approach to active immunotherapy based on modification of autologous cancer cells with the hapten, dinitrophenyl (DNP). The treatment…”
Get more information

Variability in glucose transporter-1 levels and hexokinase activity in human melanoma by Wachsberger, P R, Gressen, E L, Bhala, A, Bobyock, S B, Storck, C, Coss, R A, Berd, D, Leeper, D B

“…Melanoma exhibits heterogeneous growth patterns and widely varying sensitivities to multiple treatment modalities. This variability may reflect intrinsic…”
Get full text

Melanoma vaccines as a therapeutic option by Berd, D

Get full text

BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy by Nathan, F E, Berd, D, Sato, T, Shield, J A, Shields, C L, De Potter, P, Mastrangelo, M J

“…We conducted a phase II trial of bleomycin+vincristine+lomustine+dacarbazine (BOLD) with intercycle alpha interferon-2b in previously untreated patients with…”
Get more information

Gene therapy for human cancer: an essay for clinicians by Mastrangelo, M J, Berd, D, Nathan, F E, Lattime, E C

“…In the last decade our understanding of the processes that govern growth and differentiation has become quite sophisticated. A variety of tumor suppressor…”
Get more information

Active specific immunization in the treatment of patients with melanoma by Mastrangelo, M J, Maguire, Jr, H C, Sato, T, Nathan, F E, Berd, D

“…The bonafide albeit infrequent examples of tumor regression observed with whole tumor cell vaccines give evidence for the hypothesis that active specific…”
Get more information

Treatment of human melanoma with a hapten-modified autologous vaccine by Berd, D, Maguire, Jr, H C, Mastrangelo, M J

Get more information

Combination chemotherapy of metastatic melanoma by Berd, D, Mastrangelo, M J

Get more information

Effects of anticancer drugs on the immune system in humans by Ehrke, M J, Mihich, E, Berd, D, Mastrangelo, M J

Get more information

Autologous, hapten-modified vaccine as a treatment for human cancers by Berd, David

“…We have devised a novel approach to active immunotherapy based on modification of autologous cancer cells with the hapten, dinitrophenyl (DNP). The treatment…”
Get full text

Melanoma and vitiligo : immunology's Grecian urn by BERD, D, MASTRANGELO, M. J, LATTIME, E, SATO, T, MAGUIRE, H. C

Get full text

Low doses of chemotherapy to inhibit suppressor T cells by Berd, D

Get more information

The Dartmouth Regimen: Gone or Going Strong? by McClay, Edward F., Berd, David, Mastrangelo, Michael J.

Get full text

Detection of specific genetic alterations in cancer cells by Huebner, K, Ohta, M, Lubinski, J, Berd, D, Magüire, Jr, H C

“…The genetic changes found in human neoplasms suggest that hematopoietic tumors develop mainly from inappropriate expression (usually overexpression) of a…”
Get more information